Image

Safety and Efficacy of Remote Ischemic Conditioning for Acute Ischemic Stroke

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning for acute ischemic stroke.

Description

In this study, 2210 cases of ischemic stroke in 72 hours were included in 10 centers in China according to the principle of random, and parallel control. The experimental group receive basic treatment and remote ischemic conditioning for 200mmHg, 2 times per day for 7 consecutive days. The control group receive basic treatment and remote ischemic conditioning control for 60mmHg, 2 times per day for 7 consecutive days. Two groups will be followed up for 90 days to evaluate the efficacy and safety of remote ischemic conditioning in treating acute ischemic stroke.

Eligibility

Inclusion Criteria:

  • 1) Age≥18 years, regardless of sex.
  • 2) Patients with clinically definite diagnosis of acute ischemic stroke and able to commence RIC treatment within 72 hours of stroke onset.
  • 3) Baseline NIHSS ≥ 4, ≤ 24.
  • 4) Baseline mRS ≤ 2;
  • 5) Signed and dated informed consent is obtained.

Exclusion Criteria:

  • 1) Patients who undergo thrombolytic therapy or endovascular treatment.
  • 2) The patients who had the contraindication of remote ischemic conditioning treatment, such as severe soft tissue injury, fracture, or vascular injury in the upper limb. Acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc.
  • 3) Other intracranial lesions, such as cerebrovascular malformation cerebral venous diseases, tumors,s and other diseases involving the brain.
  • 4) Pregnant or lactating women.
  • 5) Previous remote ischemic conditioning therapy or similar treatment.
  • 6) Severe hepatic and renal dysfunction.
  • 7) Patients with a life expectancy of less than 3 months or patients unable to complete the study for other reasons.
  • 8) Unwilling to be followed up or treated for poor compliance.
  • 9) He/She is participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to admission.
  • 10) Other conditions that the researchers think are not suitable for the group.

Study details

Acute Ischemic Stroke

NCT04980651

Yi Yang

7 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.